MARKET

IDXX

IDXX

IDEXX Labs
NASDAQ

Real-time Quotes | Nasdaq Last Sale

364.70
+9.94
+2.80%
After Hours: 366.00 +1.3 +0.36% 19:58 09/21 EDT
OPEN
351.33
PREV CLOSE
354.76
HIGH
365.24
LOW
348.69
VOLUME
532.11K
TURNOVER
--
52 WEEK HIGH
407.86
52 WEEK LOW
168.65
MARKET CAP
31.02B
P/E (TTM)
68.92
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Tracking Ron Baron's BAMCO Portfolio - Q2 2020 Update
BAMCO’s 13F portfolio value increased from $20.41B to $27.66B this quarter.Ron Baron added ZoomInfo Tech and increased Zillow Group during the quarter.Their top five positions are at ~22% of the overall portfolio.
Seekingalpha · 5h ago
Hedge Funds Never Been This Bullish On IDEXX Laboratories, Inc. (IDXX)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of June 30th, when the S&P 500 Index
Insider Monkey · 09/09 14:17
Did The Underlying Business Drive IDEXX Laboratories' (NASDAQ:IDXX) Lovely 429% Share Price Gain?
For many, the main point of investing in the stock market is to achieve spectacular returns. And highest quality...
Simply Wall St. · 08/31 17:34
Idexx (IDXX) Up 2.6% Since Last Earnings Report: Can It Continue?
Zacks · 08/30 16:30
These 7 Funds Beat the Market Without Owning the FAAMG Stocks
Facebook, Apple, Amazon, Microsoft, and Google parent Alphabet make up nearly a quarter of the S&P 500. It isn’t easy to beat the market without owning 25%...
marketwatch.com · 08/28 20:27
Nevro Earns Relative Strength Rating Upgrade; Hits Key Benchmark
Investor's Business Daily · 08/26 18:27
Credit Suisse Maintains Outperform on IDEXX Laboratories, Raises Price Target to $422
Credit Suisse maintains IDEXX Laboratories (NASDAQ:IDXX) with a Outperform and raises the price target from $415 to $422.
Benzinga · 08/17 12:40
Top Buys From The Best Money Managers (Q2 2020)
On August 14th, institutional investment managers with more than $100 million AUM disclosed their positions at the end of Q2 2020.Several stocks stand out when we look at the form 13F of some of the best-performing hedge funds.Focusing on the very best ideas, I reviewed which stocks appear the most in the top five holdings of the best hedge funds at the end of June.Several common themes appear when you look at what the top portfolio managers have been buying during the second quarter of the year.
Seekingalpha · 08/17 00:53
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average IDXX stock price target is 427.40 with a high estimate of 440.00 and a low estimate of 410.00.
EPS
Institutional Holdings
Institutions: 1.05K
Institutional Holdings: 85.27M
% Owned: 100.26%
Shares Outstanding: 85.05M
TypeInstitutionsShares
Increased
249
2.92M
New
168
167.97K
Decreased
289
4.22M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.45%
Healthcare Equipment & Supplies
-1.43%
Key Executives
President/Chief Executive Officer
Jay Mazelsky
Chairman/Independent Director
Lawrence Kingsley
President/Chief Executive Officer/Director
Jonathan Mazelsky
President/Chief Executive Officer
Jonathan Jay Mazelsky
Chief Financial Officer/Executive Vice President/Treasurer
Brian McKeon
Chief Human Resource Officer/Vice President
Giovani Twigge
Executive Vice President/General Manager
Tina Hunt
Executive Vice President/General Manager
Michael Lane
Executive Vice President
James Polewaczyk
Chief Marketing Officer/Vice President
Kathy Turner
Vice President/General Counsel/Secretary
Sharon Underberg
Director
Jonathan Ayers
Independent Director
Bruce Claflin
Independent Director
Stuart Essig
Independent Director
Rebecca Henderson
Independent Director
Daniel Junius
Independent Director
Sam Samad
Independent Director
M. Anne Szostak
Independent Director
Sophie Vandebroek
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More

Analyst Price Target

The average IDXX stock price target is 427.40 with a high estimate of 440.00 and a low estimate of 410.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About IDXX
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its segments include diagnostic and information technology-based products and services for the veterinary market, which the Company refers to as the Companion Animal Group; water quality products; diagnostic products and services for livestock and poultry health, which the Company refers to as Livestock, Poultry and Dairy, and Other operating segment, which combines and presents products for the human point-of-care medical diagnostics market with its pharmaceutical product line and its out-licensing arrangements. Its products and services include point-of-care veterinary diagnostic products, comprising instruments, consumables and rapid assay test kits, among others.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of IDEXX Laboratories, Inc. stock information, including NASDAQ:IDXX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IDXX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IDXX stock methods without spending real money on the virtual paper trading platform.